MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

CONMED Company Profile (NASDAQ:CNMD)

Consensus Ratings for CONMED (NASDAQ:CNMD) (?)
Ratings Breakdown: 2 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $53.33 (20.66% upside)

Analysts' Ratings History for CONMED (NASDAQ:CNMD)
Show:
DateFirmActionRatingPrice TargetActions
4/28/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Needham & Company LLCBoost Price TargetBuy$48.00 -> $49.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/17/2015Deutsche BankReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/22/2015Northland SecuritiesLower Price TargetMarket Perform$58.00 -> $44.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/12/2015Ladenburg ThalmannUpgradeNeutral -> Buy$55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/27/2015Piper JaffrayReiterated RatingNeutral$51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2015Northland Capital PartnersInitiated CoverageOutperform$65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2015KeyBancInitiated CoverageSector WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2015Summer StreetBoost Price TargetBuy$46.00 -> $56.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/25/2014 forward)
Earnings History for CONMED (NASDAQ:CNMD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/19/2016        
4/27/2016Q116$0.41$0.42$180.15 million$181.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2016Q415$0.51$0.52$191.03 million$191.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/21/2015Q315$0.43$0.38$173.96 million$169.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/21/2015Q215$0.44$0.36$182.40 million$181.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/22/2015Q115$0.43$0.42$176.16 million$177.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2015Q414$0.54$0.53$196.00 million$195.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2014Q314$0.39$0.44$173.30 million$175.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2014Q214$0.47$0.47$190.62 million$188.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/24/2014Q1$0.47$0.49$191.95 million$181.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/13/2014Q413$0.49$0.53$197.24 million$203.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2013Q313$0.40$0.40$186.20 million$179.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2013Q2 2013$0.44$0.43$193.55 million$193.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2013Q1 2013$0.45$0.45$196.79 million$187.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/14/2013Q4 2012$0.50$0.52$200.12 million$201.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2012$0.40$0.43ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/26/2012$0.45$0.43ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2012$0.44$0.43ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/15/2012$0.39$0.46ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2011$0.31$0.33ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2011$0.35$0.35ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2011$0.31$0.37ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2011$0.36$0.36ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for CONMED (NASDAQ:CNMD)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.37$0.52$0.44
Q2 20164$0.44$0.49$0.46
Q3 20164$0.36$0.49$0.44
Q4 20165$0.52$0.64$0.59
(Data provided by Zacks Investment Research)
Dividend History for CONMED (NASDAQ:CNMD)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
5/25/2016quarterly$0.202.05%6/13/20166/15/20167/6/2016Tweet This Announcement  Share This Announcement on StockTwits
2/23/2016quarterly$0.202.1%3/11/20163/15/20164/5/2016Tweet This Announcement  Share This Announcement on StockTwits
11/16/2015quarterly$0.201.92%12/11/201512/15/20151/5/2016Tweet This Announcement  Share This Announcement on StockTwits
8/24/2015quarterly$0.201.53%9/11/20159/15/201510/5/2015Tweet This Announcement  Share This Announcement on StockTwits
5/29/2015quarterly$0.201.44%6/11/20156/15/20157/6/2015Tweet This Announcement  Share This Announcement on StockTwits
2/25/2015quarterly$0.201.56%3/12/20153/16/20154/6/2015Tweet This Announcement  Share This Announcement on StockTwits
11/18/2014quarterly$0.201.92%12/11/201412/15/20141/5/2015Tweet This Announcement  Share This Announcement on StockTwits
8/25/2014quarterly$0.202.11%9/11/20149/15/201410/6/2014Tweet This Announcement  Share This Announcement on StockTwits
5/23/2014quarterly$0.201.8%6/12/20146/16/20147/7/2014Tweet This Announcement  Share This Announcement on StockTwits
2/27/2014quarterly$0.201.72%3/13/20143/17/20144/7/2014Tweet This Announcement  Share This Announcement on StockTwits
10/28/2013quarterly$0.2012/12/201312/16/20131/6/2014Tweet This Announcement  Share This Announcement on StockTwits
8/27/2013quarterly$0.151.91%9/12/20139/16/201310/4/2013Tweet This Announcement  Share This Announcement on StockTwits
5/24/2013quarterly$0.151.76%6/13/20136/17/20137/8/2013Tweet This Announcement  Share This Announcement on StockTwits
2/27/2013quarterly$0.151.93%3/13/20133/15/20134/5/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for CONMED (NASDAQ:CNMD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/3/2016Luke A PomilioCFOSell4,400$41.56$182,864.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2016Charles FarkasDirectorBuy338$42.04$14,209.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2016Mark D SnyderEVPSell2,940$41.32$121,480.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2016John L WorkmanDirectorBuy2,500$39.85$99,625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2016Jerome J LandeDirectorSell1,630,800$38.28$62,427,024.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Charles FarkasDirectorBuy332$42.18$14,003.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2015David M BronsonDirectorBuy1,500$41.01$61,515.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2015Jo Ann GoldenDirectorSell1,000$56.03$56,030.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2015Stephen MandiaDirectorSell14,000$55.62$778,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2015Pat BeyerInsiderBuy5,000$53.36$266,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/30/2015Stephen MandiaDirectorSell3,899$49.97$194,833.03View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2014Stephen MandiaDirectorSell4,500$43.23$194,535.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Dirk KuyperDirectorSell1,000$42.85$42,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2014Joseph G DarlingEVPSell4,270$42.00$179,340.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2014Robert D Shallish JrCFOSell10,410$41.67$433,784.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2014William AbrahamEVPSell16,062$39.91$641,034.42View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2014William AbrahamEVPSell7,423$38.36$284,746.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/21/2014William AbrahamEVPSell15,986$37.71$602,832.06View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2014William AbrahamEVPSell5,312$37.75$200,528.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/31/2014Curt R HartmanCEOBuy10,000$39.25$392,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2014Bruce DanielsDirectorSell1,600$39.31$62,896.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2014Joseph J CorasantiCEOSell109,035$39.25$4,279,623.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2013Joseph J CorasantiCEOSell80,148$36.47$2,922,997.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2013Bruce DanielsDirectorSell4,500$36.43$163,935.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/13/2013Joseph CorasantiCEOSell44,852$33.04$1,481,910.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2013William AbrahamSVPSell7,423$33.48$248,522.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2013Dirk KuyperDirectorBuy1,000$31.63$31,630.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2013Daniel JonasVPSell2,000$32.42$64,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2013Heather L CohenVPSell1,200$32.59$39,108.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/31/2013Luke A PomilioVPSell2,556$33.19$84,833.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2013Heather L CohenVPSell4,514$34.31$154,875.34View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2013Robert D Shallish JrCFOSell10,000$34.35$343,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/15/2013Stuart J SchwartzDirectorSell1,000$30.32$30,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for CONMED (NASDAQ:CNMD)
DateHeadline
06/22/16 03:30 PMCONMED Corporation (CNMD) is Trading Higher on Unusual Volume for June 20
06/20/16 09:38 AMDENTSPLY Sirona (XRAY): Q1 Strong, Expansion on Track
06/17/16 11:11 AMCONMED Corporation (CNMD) is Trading Lower on Unusual Volume for June 15
06/09/16 03:17 PMEx-Dividend Reminder: UGI, Thermo Fisher Scientific and Conmed
06/06/16 04:06 PMCONMED Corp. – Value Analysis (NASDAQ:CNMD) : June 6, 2016 -
06/03/16 07:05 AMCONMED Corp. breached its 50 day moving average in a Bullish Manner : CNMD-US : June 3, 2016 -
05/28/16 01:33 PMEarnings Review and Stock Rundown for CONMED Corporation (NASDAQ:CNMD) - Wall Street Hints and News - Earnings Review and Stock Rundown for CONMED Corporation (NASDAQ:CNMD)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting CONMED Corporation (NASDAQ:CNMD) to ...and more »
05/26/16 03:37 PMCONMED CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events -
05/24/16 01:59 PMETF’s with exposure to CONMED Corp. : May 24, 2016 -
05/02/16 03:49 PMCONMED CORP Files SEC form 10-Q, Quarterly Report -
04/29/16 09:09 AMCONMED Corp. :CNMD-US: Earnings Analysis: Q1, 2016 By the Numbers -
04/29/16 07:54 AMCONMED (CNMD) Q1 Earnings Miss, Sales Beat; Stock Down -
04/28/16 01:53 AMEdited Transcript of CNMD earnings conference call or presentation 27-Apr-16 8:30pm GMT -
04/27/16 04:46 PMConmed reports 1Q loss -
04/27/16 03:27 PMCONMED Corporation Announces First Quarter 2016 Financial Results - [at noodls] - UTICA, N.Y.--(BUSINESS WIRE)--Apr. 27, 2016-- CONMED Corporation (Nasdaq:CNMD) today announced financial results for the first quarter ended March 31, 2016. First Quarter 2016 Highlights Sales were $181.2 ...
03/31/16 12:55 PMScopia Capital Boosts Stake in CONMED, Plus 2 Other Ongoing Activist Battles -
03/10/16 12:01 AMCONMED Corp (CNMD): Scopia Capital Isn’t Done Buying Shares -
02/23/16 04:52 PM13D Filing: Scopia Capital Reveals Big Stake in Conmed Corp (CNMD) -
02/23/16 03:32 PMCONMED CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and Exh -
02/23/16 07:00 AMCONMED Corporation Adds Health Care Executive Martha Goldberg Aronson to its Board of Directors - [Business Wire] - CONMED Corporation today announced that it has added Martha Goldberg Aronson to its Board of Directors, effective immediately.
02/23/16 07:00 AMCONMED Corporation Announces Quarterly Cash Dividend - [Business Wire] - CONMED Corporation today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on April 5, 2016 to all shareholders of record as of March 15, 2016.
02/23/16 05:03 AMCONMED CORP Files SEC form 10-K, Annual Report -
02/14/16 01:19 PMConmed Corporation (NASDAQ:CNMD) Shorted Shares Decreased By 6.48% - fdanewsalert.com - Conmed Corporation (NASDAQ:CNMD) Shorted Shares Decreased By 6.48%fdanewsalert.comCONMED Corporation (NASDAQ:CNMD) has declined 37.34% since July 10, 2015 and is downtrending. It has underperformed by 27.14% the S&P500. CONMED Corporation is a medical technology company. The company has a market cap of $1.01 billion.
02/01/16 03:23 PMCONMED Corporation to Present at the LEERINK Partners 5th Annual Global Healthcare Conference - [at noodls] - --(BUSINESS WIRE)--Feb. 1, 2016-- (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and , Chief Financial Officer, will present at the 5th Annual Global Healthcare ...
01/30/16 12:36 PMLeerink Partners Remains Bullish as Conmed's (CNMD) Growth Acceleration Shows Evolving Turnaround - Claim your 2-week free trial here. Leerink Partners reiterated an Outperform rating on CONMED (NASDAQ: CNMD), and cut the price target to $50.00 (from $51.00), following the company's 4Q report. Results were marked by solid growth acceleration in ortho and ...
01/29/16 12:52 PMConmed Corp. Q4 Income Declines 2% - (RTTNews.com) - Conmed Corp. ( CNMD) released a profit for fourth quarter that decreased from last year. The company said its earnings declined to $14.46 million, or $0.52 per share. This was lower than $14.73 million, or $0.53 per share, in last year's ...
01/29/16 11:46 AMCONMED Corp. Earnings Analysis: Q4, 2015 By the Numbers -
01/28/16 10:15 AMCONMED Beats Q4 Earnings & Sales, FY16 View Impressive -
01/27/16 11:05 PMEdited Transcript of CNMD earnings conference call or presentation 27-Jan-16 9:30pm GMT -
01/27/16 08:04 PMCONMED Corporation (CNMD) Releases Earnings Results, Beats Expectations By $0.01 EPS - Analyst Rating Reports - CONMED Corporation (CNMD) Releases Earnings Results, Beats Expectations By $0.01 EPSAnalyst Rating ReportsCONMED Corporation (CNMD) issued its quarterly earnings results on Wednesday, Jan-27-2016. The company reported $0.52 EPS for the quarter, beating the analyst consensus estimate by $0.01. Analysts had a consensus of $0.51. The company had ...
01/27/16 04:00 PMCONMED CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -
01/27/16 03:34 PMCONMED Corporation Announces Fourth Quarter and Fiscal Year 2015 Financial Results - [at noodls] - --(BUSINESS WIRE)--Jan. 27, 2016-- (Nasdaq:CNMD) today announced financial results for the fourth quarter and fiscal year ended . Fourth Quarter 2015 Highlights Sales were , a decrease of 2.0% compared ...
01/27/16 03:30 PMConmed Corp Earnings Call scheduled for 4:30 pm ET today -
01/27/16 03:04 PM4:04 pm CONMED beats by $0.01, reports revs in-line; guides FY16 above consensus -
01/27/16 06:07 AMQ4 2015 Conmed Corp Earnings Release - After Market Close -
01/20/16 11:53 AMConmed Corp. (CNMD) Hits New 52-week Low During January 19 Session - Equities.com - Conmed Corp. (CNMD) Hits New 52-week Low During January 19 SessionEquities.comConmed Corp. (CNMD) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $39.27, Conmed Corp. dropped to $37.47 for a new 52-week low. By the closing bell, the company's stock was at $37.85 a ...and more »
01/15/16 07:22 AMCONMED Corporation to Announce Fourth Quarter and Fiscal Year 2015 Financial Results on January 27, 2016 - [at noodls] - --(BUSINESS WIRE)--Jan. 15, 2016-- (NASDAQ:CNMD) today announced that it will report financial results for the fourth quarter and fiscal year 2015 after the market close on . The Company's management will ...
01/08/16 07:21 AMCONMED Corp. breached its 50 day moving average in a Bearish Manner : January 8, 2016 -
01/05/16 09:10 AMCONMED (CNMD) Seals SurgiQuest Buy, Boosts Surgical Unit -
01/04/16 04:11 PMCONMED CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Ob -
01/04/16 04:00 PMCONMED Completes Acquisition of SurgiQuest, Inc. - [at noodls] - --(BUSINESS WIRE)--Jan. 4, 2016-- (NASDAQ: CNMD) today announced that it has completed its previously announced acquisition of privately-held (SurgiQuest), which will become part of the Advanced Surgical ...
12/23/15 07:06 AMCONMED Corp. breached its 50 day moving average in a Bullish Manner : December 23, 2015 -
12/17/15 03:46 PMCONMED Corporation to Present at the Annual J.P. Morgan Healthcare Conference - [at noodls] - --(BUSINESS WIRE)--Dec. 17, 2015-- (NASDAQ:CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and , Chief Financial Officer, will present at the 34th Annual at on in A live ...
12/08/15 12:16 PMCONMED CORP Financials -
11/17/15 03:44 PMHome Depot and Angie's List are big market movers -
11/17/15 01:50 PMCONMED Inks Agreement to Acquire SurgiQuest; Stock Gains -
11/17/15 09:10 AMCompany News for November 17, 2015 -
About CONMED

CONMED logoCONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. Its products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. Its product lines consist of orthopedic surgery, general surgery and surgical visualization. Its orthopedic surgery product lines include sports medicine, powered surgical instruments, and sports biologics and tissue. Its general surgery product line offers a range of products in the areas of advanced surgical, endoscopic technologies and critical care. Its surgical visualization product line offers imaging systems for use in minimally invasive orthopedic and general surgery procedures. Its products are distributed domestically directly to over 6,000 hospitals and other healthcare institutions, as well as through medical specialty distributors.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: CNMD
  • CUSIP: 20741010
Key Metrics:
  • Previous Close: $45.50
  • 50 Day Moving Average: $41.79
  • 200 Day Moving Average: $40.91
  • P/E Ratio: 56.59
  • P/E Growth: 2.12
  • Market Cap: $1.23B
  • Current Quarter EPS Consensus Estimate: $1.98 EPS
Additional Links:
CONMED (NASDAQ:CNMD) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha